Artroa stands as a pioneering force in the realm of osteoarthritis research, dedicated to advancingthe field through groundbreaking discoveries, innovative diagnostics, and novel treatments. At the heart of Artroa´s mission is a commitment to improving the lives of horses affected by osteoarthritis,transforming the landscape of musculoskeletal healthcare.
Leading in Patents & Innovation
Artroa is a trailblazer in innovation, holding numerous patents for cutting-edge technologies that have revolutionized the diagnosis and treatment of osteoarthritis. These patents are a testament to the company´s commitment to pushing the boundaries of what is possible in the fight against this debilitating condition.
Early Diagnosis through Biomarkers:
Artroa´s groundbreaking research has led to the identification of specific biomarkers that enable the
early detection of osteoarthritis. Through advanced molecular analysis and biomarker identification,
Artroa´s diagnostic tools can pinpoint the presence of osteoarthritis in its nascent stages. This early
diagnosis empowers veterinarians to intervene proactively, potentially halting the progression of the
disease before it causes significant damage.
A Novel Disease-Modifying Drug
:Central to Artroa´s contributions is the development of a groundbreaking disease-modifying drug. This pharmaceutical marvel represents a paradigm shift in osteoarthritis treatment. By targeting the underlying mechanisms of the disease (healing the cells), this novel drug not only alleviates symptoms (lameness) but also actively slowing down the progression of osteoarthritis. Artroa´s drug offers newfound hope to horses, promising a future where osteoarthritis can be not just managed but effectively halted in its tracks.
Artroa´s approach is deeply individual-centric. By focusing on early diagnosis and offering a disease-modifying drug, Artroa ensures that horses receive timely, personalized, and effective care
Do you want more information about Artroa?
Contact us here